Hong Yuen Wong

发表

Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells

Hiroyuki Konishi, David Cosgrove, Yuko Konishi, 2011, Proceedings of the National Academy of Sciences.

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

Antonio C. Wolff, Leslie Cope, Vered Stearns, 2014, Clinical Cancer Research.

ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients

Daniel F. Hayes, Arul M. Chinnaiyan, Heather A. Parsons, 2015, Clinical Cancer Research.

ESR 1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients

Daniel F. Hayes, Arul M. Chinnaiyan, Heather Parsons, 2015 .

Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects

L. Dillon, C. Hourigan, D. Brander, 2020, American journal of hematology.

A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers.

P. Argani, A. Wolff, A. Cimino-Mathews, 2014, Human pathology.

NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome

C. Hourigan, B. Paluch, K. Odunsi, 2017, Clinical Cancer Research.

NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model

B. Park, D. Rosen, P. Hurley, 2022, Oncotarget.

Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA.

B. Park, P. Hurley, J. Beaver, 2015, Clinical biochemistry.

Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

S. Herrell, D. Penson, B. Park, 2022, Nature Communications.

The role of targeted therapy and biomarkers in breast cancer treatment

C. Hudis, W. Gradishar, H. Rugo, 2012, Clinical & Experimental Metastasis.

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response

K. Lindblad, M. Goswami, Catherine Lai, 2018, bioRxiv.

A distinct repertoire of cancer‐associated fibroblasts is enriched in cribriform prostate cancer

J. Gordetsky, T. Lotan, P. Hurley, 2021, The journal of pathology. Clinical research.

Ki-67 is required for maintenance of cancer stem cells but not cell proliferation

P. Argani, J. Hicks, A. D. De Marzo, 2016, Oncotarget.

HER2 missense mutations have distinct effects on oncogenic signaling and migration

R. Bose, A. Cimino-Mathews, K. Konstantopoulos, 2015, Proceedings of the National Academy of Sciences.

Functional isogenic modeling of BRCA1 alleles reveals distinct carrier phenotypes

B. Park, A. Meeker, C. Heaphy, 2015, Oncotarget.

PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells

B. Park, H. Konishi, M. Mohseni, 2011, Cancer biology & therapy.

TMSB 4 Y is a Candidate Tumor Suppressor on the Y Chromosome and is Deleted in Male Breast Cancer

P. Argani, B. Park, A. Meeker, 2016 .

TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer

P. Argani, B. Park, A. Meeker, 2015, Oncotarget.

Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones.

M. Sanders, B. Park, D. Rosen, 2021, The Journal of clinical investigation.

Analysis of BRCA2 loss of heterozygosity in tumor tissue using droplet digital polymerase chain reaction.

P. Argani, S. Wheelan, J. Beaver, 2014, Human pathology.

MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers

R. Scharpf, P. Argani, A. Cimino-Mathews, 2014, Proceedings of the National Academy of Sciences.

NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability

R. Scharpf, B. Park, M. Mohseni, 2015, Proceedings of the National Academy of Sciences.

A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations

A. Pandey, Xinyan Wu, M. S. Zahari, 2015, Proteomics.

Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation.

P. Argani, B. Park, H. Konishi, 2013, Cancer research.

Molecular and Cellular Pathobiology Single Copies of Mutant KRAS and Mutant PIK 3 CA Cooperate in Immortalized Human Epithelial Cells to Induce Tumor Formation

P. Argani, B. Park, H. Konishi, 2013 .

Plasma tumor DNA: on your markers, get set, go!

B. Park, Hong Yuen Wong, 2014, Annals of translational medicine.

PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity

B. Park, D. Rosen, P. Hurley, 2017, Breast Cancer Research and Treatment.

TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer

P. Argani, B. Park, A. Meeker, 2015, Oncotarget.

The role of targeted therapy and biomarkers in breast cancer treatment

C. Hudis, W. Gradishar, H. Rugo, 2012, Clinical & Experimental Metastasis.